阿奇霉素联合头孢哌酮钠舒巴坦钠治疗小儿肺炎的疗效研究

Analysis of the Therapeutic Effect of Azithromycin Combined with Cefoperazone Sodium and Sulbactam Sodium in the Treatment of Pediatric Pneumonia

研究阿奇霉素联合头孢哌酮钠舒巴坦钠治疗小儿肺炎的效果。选择2022年10月—2023年10月贵阳市第六医院收治的52例肺炎患儿为研究对象,运用随机数字表法将全部患儿分为研究组和对照组,每组各26例。对照组采用阿奇霉素(序贯)进行治疗,研究组在对照组的基础上联合使用头孢哌酮钠舒巴坦钠进行治疗,评估两组患儿治疗效果。结果表明,与对照组相比,研究组治疗总有效率更高(P<0.05);研究组症状持续时间更短(P<0.05);研究组不良反应发生率虽较对照组高,但两组患儿对比无统计学差异(P>0.05);治疗后,研究组肺功能指标均更优(P<0.05)。研究发现,运用阿奇霉素+头孢哌酮钠舒巴坦钠治疗小儿肺炎,疗效显著,治疗安全性有保障,值得推广运用。

Study the efficacy of azithromycin combined with cefoperazone sodium and sulbactam sodium in the treatment of pediatric pneumonia.52 children with pneumonia admitted to Guiyang Sixth Hospital from October 2022 to October 2023 were selected as the research subjects.The random number table method was used to divide all children into a study group and a control group,with 26 cases in each group.The control group was treated with azithromycin(sequential),while the study group was treated with a combination of cefoperazone sodium and sulbactam sodium on the basis of the control group.The therapeutic effects of the two groups of children were evaluated.The results showed that compared with the control group,the total effective rate of the study group was higher(P<0.05);The duration of symptoms in the research group was shorter(P<0.05);Although the incidence of adverse reactions in the study group was higher than that in the control group,there was no statistically significant difference between the two groups of children(P>0.05);After treatment,the lung function indicators of the study group were all better(P<0.05).Research has found that the use of azithromycin+cefoperazone sodium and sulbactam sodium in the treatment of pediatric pneumonia has significant therapeutic effects and guaranteed treatment safety,and is worthy of promotion and application.